SGLT2 Inhibitor Use in CKD Stage 4: Initiation, Continuation, and Monitoring Guidelines

Initiation Thresholds

Recommendations for Initiation in CKD Stage 4 (eGFR 20–29 mL/min/1.73 m²)

Continuation Strategy

Safety and Monitoring

Populations Where Recommendations May Not Apply

Evidence Quality